A02 RFI for BWI PT Barrier - FInal 3 December 2025.docx

REQUEST FOR INFORMATION (RFI)

for

BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T):

BARRIER COMBINATION PRODUCT DEVELOPMENT

THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS (RFQ). IT IS STRICTLY A REQUEST FOR INFORMATION (RFI). NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT/ORDER WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT.

Disclaimer: The purpose of this RFI notice is to gain market knowledge. This notice does not obligate the Government to award a contract/order or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's solution and qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a synopsis and/or solicitation may or may NOT be published at a future date and time.

1.0 RFI Number: HT9427-26-RFI-BWI-PT

2.0 RFI Issuing Office: Defense Health Agency Contracting Activity - Research & Development (DHACA-R&D)

3.0 RFI Issue Date: December 3, 2025

4.0 RFI Title: BATTLEFIELD WOUND INFECTION AND TREATMENT: BARRIER COMBINATION PRODUCT DEVELOPMENT

5.0 Agency: Defense Health Agency (DHA)

6.0 Office: Operational Medical Systems (OPMED) Warfighter Protection and Acute Care (WPAC) Project Management Office (PMO)

7.0 Location: Frederick, MD (on Fort Detrick)

8.0 Contract Type: Unknown

In accordance with Federal Acquisition Regulation (FAR) 15.201 "Exchange with industry before receipt of proposals," this RFI is for information and planning purposes only at this time and shall not be construed as a solicitation or as an obligation on the part of the DHA, DHACA, or any collaborative Department of Defense (DoD) activities.

This RFI is for information and planning purposes only and is neither to be construed as a commitment by the Government nor will the Government pay for information solicited. Respondents are solely responsible for all expenses associated with responding to this RFI. No evaluation letters and/or results will be issued to the respondents. Currently, no solicitation exists; therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPTED OR RETURNED.

Neither unsolicited proposals nor any other kind of offer will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked “Proprietary” will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.

9.0 Background: The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements.

10.0 Objective and Purpose/Scope: DHA’s OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged.

This RFI seeks responses to the barrier combination component of this FoS only.

Although there is an emphasis on use at the point of injury, this capability will likely be used across roles of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial market with respect to wound care and infection prevention.

The barrier combination product must have the following minimum essential characteristics:

Please refer to Attachment 3 - Minimum Essential Characteristics (MECS)

11.0 North American Industry Classification System (NAICS) Code: Unknown

12. RFI Attachments: The following documents are attached to the RFI

· Attachment 1: Technical Readiness Level (TRL) (Reference Only)

· Attachment 2: Company & Product Information

· Attachment 3: Minimum Essential Characteristics (MECS)

13. Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to:

Jeanette Collins via email at: jeanette.m.collins4.civ@health.mil Email Subject/title: "RFI response for HT9427-26-RFI-BWI-PT”

14. SUBMISSION INSTRUCTIONS:

14.1 The Government appreciates responses from ALL capable and qualified sources, especially small businesses.

14.2 Interested firms should submit a response that demonstrates the Respondent's ability to perform the scope of work identified in this RFI.

14.3 Format specifications include Arial 12-point font, single spaced, single sided, 8.5 by 11- inch paper with 1-inch margins. All submissions shall be made electronically (as described above) and be in one of the following formats: Microsoft Word or searchable Adobe PDF.

Responses should adhere to the following formatting and outline instructions:

Cover Page (1 page)

· Title

· Organization

· Responding technical and administrative points of contact (names, addresses, phone, fax number and email addresses)

· Topic area: “BATTLEFIELD WOUND INFECTION AND TREATMENT (BWI P&T)”

14.4 Completed Attachments: 2 and 3

15.0 Confidentiality: All 'Proprietary', 'Classified', 'Confidential', or 'Sensitive' information shall be marked as such and will be treated accordingly. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

(End of RFI)